KRONOXSpecialty Chemicals
Kronox Lab Science Ltd — Profit & Loss Statement
₹97.02
-4.42%
Kronox Lab Science Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Unusual Items | 0.00 | 24000.00 | 0.28 Cr | 0.03 Cr | 0.03 Cr |
| Total Unusual Items Excluding Goodwill | 0.00 | 24000.00 | 0.28 Cr | 0.03 Cr | 0.03 Cr |
| Interest Income | 1.78 Cr | 1.02 Cr | 0.42 Cr | 0.32 Cr | 0.28 Cr |
| Net Income From Continuing And Discontinued Operation | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Total Expenses | 68.00 Cr | 62.49 Cr | 75.08 Cr | 64.33 Cr | — |
| Diluted Average Shares | 3.71 Cr | 3.71 Cr | 3.71 Cr | 3.71 Cr | 3.71 Cr |
| Basic Average Shares | 3.71 Cr | 3.71 Cr | 3.71 Cr | 3.71 Cr | 3.71 Cr |
| Diluted EPS | 6.91 | 5.75 | 4.48 | 3.67 | 2.62 |
| Basic EPS | 6.91 | 5.75 | 4.48 | 3.67 | 2.62 |
| Diluted NI Availto Com Stockholders | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Net Income Common Stockholders | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Net Income Including Noncontrolling Interests | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Net Income Continuous Operations | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Tax Provision | 8.80 Cr | 7.26 Cr | 5.71 Cr | 4.73 Cr | — |
| Pretax Income | 34.27 Cr | 28.61 Cr | 22.33 Cr | 18.36 Cr | — |
| Other Non Operating Income Expenses | 5000.00 | 8000.00 | 0.26 Cr | 0.17 Cr | — |
| Special Income Charges | 0.00 | 24000.00 | 0.28 Cr | 0.03 Cr | 0.03 Cr |
| Write Off | 0.00 | -24000.00 | -70000.00 | -80000.00 | 20000.00 |
| Net Non Operating Interest Income Expense | 1.78 Cr | 1.02 Cr | 0.33 Cr | -0.09 Cr | — |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.09 Cr | 0.41 Cr | — |
| Interest Income Non Operating | 1.78 Cr | 1.02 Cr | 0.42 Cr | 0.32 Cr | 0.28 Cr |
| Operating Income | 32.19 Cr | 27.37 Cr | 20.50 Cr | 17.92 Cr | — |
| Operating Expense | 17.08 Cr | 16.63 Cr | 20.20 Cr | 16.93 Cr | — |
| Other Operating Expenses | 2.14 Cr | 1.65 Cr | 1.82 Cr | 1.33 Cr | — |
| Depreciation And Amortization In Income Statement | 1.38 Cr | 1.29 Cr | 1.50 Cr | 2.03 Cr | — |
| Depreciation Income Statement | 1.38 Cr | 1.29 Cr | 1.50 Cr | 2.03 Cr | — |
| Selling General And Administration | 5.98 Cr | 4.80 Cr | 7.34 Cr | 5.98 Cr | 4.63 Cr |
| Selling And Marketing Expense | 5.05 Cr | 3.98 Cr | 6.49 Cr | 5.64 Cr | 3.93 Cr |
| General And Administrative Expense | 0.93 Cr | 0.82 Cr | 0.85 Cr | 0.34 Cr | 0.70 Cr |
| Gross Profit | 49.27 Cr | 44.00 Cr | 40.70 Cr | 34.85 Cr | — |
| Cost Of Revenue | 50.92 Cr | 45.86 Cr | 54.88 Cr | 47.40 Cr | — |
| Total Revenue | 100.19 Cr | 89.86 Cr | 95.58 Cr | 82.25 Cr | — |
| Operating Revenue | 100.19 Cr | 89.86 Cr | 95.58 Cr | 82.25 Cr | — |
| Tax Effect Of Unusual Items | 0.00 | 6087.90 | 0.07 Cr | 87579.41 | — |
| Tax Rate For Calcs | 0.26 | 0.25 | 0.26 | 0.26 | — |
| Normalized EBITDA | 35.65 Cr | 29.89 Cr | 23.64 Cr | 20.75 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 25.47 Cr | 21.35 Cr | 16.62 Cr | 13.63 Cr | — |
| Reconciled Depreciation | 1.38 Cr | 1.29 Cr | 1.50 Cr | 2.03 Cr | — |
| Reconciled Cost Of Revenue | 50.92 Cr | 45.86 Cr | 54.88 Cr | 47.40 Cr | — |
| EBITDA | 35.65 Cr | 29.90 Cr | 23.92 Cr | 20.79 Cr | — |
| EBIT | 34.27 Cr | 28.61 Cr | 22.42 Cr | 18.76 Cr | — |
| Net Interest Income | 1.78 Cr | 1.02 Cr | 0.33 Cr | -0.09 Cr | — |
| Interest Expense | 0.00 | 0.00 | 0.09 Cr | 0.41 Cr | — |
| Normalized Income | 25.47 Cr | 21.35 Cr | 16.41 Cr | 13.60 Cr | — |
| Rent Expense Supplemental | — | — | 0.00 | 0.04 Cr | 0.04 Cr |
| Other Special Charges | — | — | -0.27 Cr | -0.03 Cr | -0.03 Cr |
| Rent And Landing Fees | — | — | 0.00 | 0.04 Cr | 0.04 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kronox Lab Science Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.